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Abstract
Published rates of comorbidity between pediatric bipolar disorder (PBD) and attention-deficit/
hyperactivity disorder (ADHD) have been higher than would be expected if they were independent
conditions, but also dramatically different across different studies. This review examines processes
that could artificially create the appearance of comorbidity or substantially bias estimates of the
ADHD-BPD comorbidity rate, including: categorization of dimensional constructs, overlap among
diagnostic criteria, over-splitting, developmental sequencing, and referral or surveillance biases.
Evidence also suggests some mechanisms for “true” BPD-ADHD comorbidity, including shared
risk factors, distinct subtypes, and weak causal relationships. Keys to differential diagnosis include
focusing on episodic presentation and non-overlapping symptoms unique to mania.
Bipolar and ADHD Comorbidity: Both Artifact and Outgrowth of Shared
Mechanisms
“Comorbidity,” meeting criteria for more than one psychiatric disorder, is the rule--not the
exception--in both clinical and research samples. Although comorbidity is a general
phenomenon extensively reviewed (e.g., Angold, Costello, & Erkanli, 1999; Caron &
Rutter, 1991; Youngstrom, Findling, & Calabrese, 2003), the observed comorbidity of
pediatric bipolar disorder (PBD) and attention-deficit/hyperactivity disorder (ADHD) is a
recent, fascinating example that has prompted intense debate (e.g., Biederman, Klein, Pine,
& Klein, 1998; Klein, Pine, & Klein, 1998). This article uses BPD-ADHD comorbidity to
illustrate established mechanisms that could lead to co-occurrence of symptoms or entire
syndromes. After documenting the extent of comorbidity, we discuss mechanisms for
“false” or artificial comorbidity, their relevance to the BPD-ADHD axis, and some
processes that could account for “true” comorbidity between the two disorders. Our review
closes with guidance about how to decide which disorder is “primary” if enough symptoms
for both are present.
How Often Are ADHD and Bipolar Disorder Comorbid with Each Other?
The bipolar spectrum, which includes bipolar I, bipolar II, cyclothymic disorder, and bipolar
NOS, affects between 0 and 6% of youths in epidemiological samples around the world,
averaging 1.8% (Van Meter et al., under review). ADHD is far more common, with
estimated prevalences from 5 to 10% (Smith, Barkley, & Shapiro, 2007). If BPD and ADHD
were completely independent, then the only ~2% of cases with ADHD would be expected to
have BPD. Conversely, only ~8% of cases with BPD would be expected to have ADHD as
well, and only 3 youths out of every 2000 in the community would be unfortunate enough to
have both conditions. However, a recent review of six non-referred samples found that the
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rates of comorbidity tended to be elevated well above chance levels (Galanter & Leibenluft,
2008).
The rates of comorbidity in clinical samples should be higher than found in unfiltered
community samples: Because youths with both disorders would be more impaired, they
would be more likely to seek services (“Berkson's bias”; Berkson, 1946). Thus comorbid
cases would be over-represented in clinical samples. Published estimates from clinical
samples run the full gamut from 0% (Hurtig et al., 2007) to 98% (Wozniak et al., 1995),
with a meta-analysis of seven BPD studies finding an average rate of 62% also meeting
criteria for ADHD (Kowatch, Youngstrom, Danielyan, & Findling, 2005). Two things are
clear: (a) BPD-ADHD comorbidity is too common to be a chance co-occurrence of
independent phenomena, and (b) the tremendous variability of rates deserves explanation.
Is It All a Mistake? “False” Comorbidity as a Potential Explanation
Caron & Rutter (1991) delineated several mechanisms that could result in “artifactual” and
“true” comorbidity, all of which potentially contribute to some degree to the apparent
ADHD-BPD comorbidity. Possible sources of artifactual comorbidity include:
(1) Using categorical labels where dimensions might be more appropriate—
There is no hard edge separating normal development and the pathological mood states of
bipolar disorder. Nor are there clear quantitative or qualitative boundaries between disorders
within the bipolar spectrum, or between bipolar versus unipolar depression (Youngstrom,
2009). Formal statistical evaluations can find no distinct category underlying ADHD,
whether by rating scales or neuropsychological instruments (Frazier, Youngstrom, &
Naugle, 2007; Haslam et al., 2006). There is no firm boundary between the irritability or
inattention associated with bipolar disorder and the same symptoms resulting from other
syndromes. The apparent “comorbidity” appearing between BPD and ADHD could be an
artifact of drawing categorical “boxes” over what actually is a seamless spectrum of
symptoms flowing from the same developmental pathological process (see Figure 1, where
the metaphorical “tree” branches into different symptom clusters defining different
disorders).
(2) Overlap in Diagnostic Criteria—There has been much debate about symptom
overlap between ADHD and BPD (Biederman, et al., 1998; Klein, et al., 1998). Data
indicate that BPD is a distinct entity, even when eliminating the overlapping items (Kim &
Miklowitz, 2002). On the other hand, if the overlapping symptoms of inattention,
hyperactivity, impulsiveness, and irritability are eliminated from ADHD, the disorder
disappears! This suggests that in a symptom Venn diagram, ADHD could fit entirely within
BPD--rather ironic given that ADHD is the more common disorder. The nonspecificity of
irritable mood, poor concentration, and high motor activity is notorious: Not only are these
symptoms common features of mania and ADHD, but they are also diagnostic symptoms of
unipolar depression, generalized anxiety disorder, post-traumatic stress disorder, and
oppositional defiant disorder (American Psychiatric Association, 2001); and they are
common features of yet more pediatric diagnoses. Figure 2 illustrate this issue using poor
concentration as an example. Similarly, impulsiveness, another symptom ADHD and BPD
share, is found in numerous other disorders. When a symptom is counted towards more than
one diagnosis, it lowers the number of additional symptoms required to pass threshold for
the additional diagnosis. Nonspecific symptoms are like “wild cards” that can be used to
construct multiple hands, inflating comorbidity if each hand is treated as a separate
condition (Youngstrom, 2010). Because it is possible to interpret 4 wild cards as 4 aces, 4
kings, or 4 queens at will, there is some concern that “comorbidity” may just be an
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overplayed hand. How many true aces are needed to be confident that this hand should be
treated as 4 aces rather than 4 queens?
(3) Over-Splitting: Artificial Subdivision of Syndromes—There is a long and
fruitful debate between “lumpers” who favor diagnostic parsimony versus “splitters” who
prefer carefully nuanced clinical description. Over-splitting would create a falsely inflated
rate of comorbidity by treating multiple components of the same larger diagnostic entity as
separate conditions that frequently co-occur. High rates of comorbidity thus invite questions
about whether a nosological system is over-splitting.
Further, a single form of pathology can influence multiple areas of functioning, generating
“comorbidities” that are manifestations of a single problem. Diagnosing BPD and ADHD
could create artifactual comorbidity if the symptoms actually are expressions of a single
underlying process. DSM sometimes provides guidance about this. For example, anxiety
disorders should not be diagnosed as “comorbid” with mood disorders unless the anxiety
symptoms also occur outside the mood episode. However, the only direction DSM offers for
ADHD and mood disorder is criterion E, which states that ADHD should not be diagnosed if
the symptoms are better explained by another disorder. Criterion E is often neglected in
practice and even in some epidemiological studies, which tend to overdiagnose ADHD. The
notion of over-splitting is further reinforced by recent genetic studies identifying
relationships between the same single nucleotide polymorphism (e.g., SLC6A3 and
SLC6A4; Anderson et al., 2009; Cho et al., 2005; Devlin et al., 2005; Mick et al., 2008;
Retz, Thome, Blocher, Baader, & Rosler, 2002; Swanson et al., 2007) or copy number
variation (Bijlsma et al., 2009) and different neuropsychiatric conditions or even typical
functioning.
(4) Developmental Sequencing—Another possibility is that one disorder may be a
developmental precursor of another. This could be considered an example of “heterotypic
continuity,” where the same developmental process presents differently at changing ages or
social contexts, or requires time and environmental inputs to grow into a fully elaborated
form. Cyclothymic disorder and bipolar NOS are logical potential prodromes for bipolar II
and bipolar I disorder, as they already involve mood dysregulation. Roughly a third of cases
who start with these conditions “progress” to bipolar I or II within three years (Angst et al.,
2003; Birmaher et al., 2009; Lewinsohn, Klein, & Seeley, 2000). Others do not show a
manic episode, but often have a major depression (Shankman et al., 2009), leaving it
uncertain whether the illness is a bipolar depression. Roughly a third of cases also appear to
change to a different, nonbipolar diagnosis (Birmaher, et al., 2009; Shankman, et al., 2009).
Conversely, cases with other kinds of affective dysregulation that fit less clearly on the
bipolar spectrum –such as elevated profiles on the Child Behavior Checklist or having
chronic “Severe Mood Dysregulation”--, although highly impaired at follow-up, are unlikely
to develop BPD (Brotman et al., 2006; Meyer et al., 2009). This is an artificial form of
comorbidity if multiple names are being applied to what is actually a single developmental
process.
Some have speculated that ADHD might be a prodrome for bipolar disorder (Tillman &
Geller, 2006). Certainly, ADHD symptoms of are also common symptoms of PBD.
Epidemiological studies indicate a much earlier age of onset for ADHD, consistent with the
possibility of it being a precursor for bipolar disorder. However, longitudinal studies of
cohorts with ADHD have found that few cases actually develop bipolar disorder (Galanter et
al., 2003; Hazell, Carr, Lewin, & Sly, 2003). Further, many adults with bipolar disorder
never had diagnosed ADHD (Galanter & Leibenluft, 2008). Clearly ADHD and PBD are not
always different labels for the same condition at varying ages.
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(5) Referral or Surveillance Biases—Referral or surveillance biases have had
substantial impact on some published findings with regard to PBD. One group's early studies
of PBD ascertained cases from an ADHD clinic, with the result that almost 100% of cases
with bipolar disorder also met criteria for ADHD (Wozniak, et al., 1995). Subsequent
publications have all found lower rates of ADHD in cohorts with PBD (although still quite
high), making clear that the high estimate was a consequence of the recruitment pattern, not
a product of PBD itself (Kowatch, et al., 2005). There is not strong evidence that rates of
“comorbid” ADHD in PBD cases exceed rates of ADHD in nonbipolar cases drawn from
the same clinical settings.
Clinical samples also have other potential confounds that could distort our understanding of
comorbidity. Clinical samples often underestimate the rate of hypomania, for example,
because hypomania does not create enough impairment to motivate treatment seeking.
Research with college student samples finds people with recurrent hypomanias but no
lifetime history of depression or mania (Alloy et al., 2008; Depue, Krauss, Spoont, & Arbisi,
1989). In fact, it is questionable whether recurrent hypomania without impairment is a
disorder, although it might share some of the processes.
Surveillance biases are a major issue in studying PBD. Older research systematically
underestimated the rates of hypomania, mania, and mixed episodes in youth, especially
when prevailing theory held that these would only begin to manifest in adolescence, much as
was the belief with unipolar depression in previous decades (Kovacs, 1989). Conversely,
studies of adults with bipolar disorder often failed to formally assess for ADHD because it
was assumed to be a pediatric illness (cf. Kessler, Berglund, Demler, Jin, & Walters, 2005;
Nierenberg et al., 2005) despite an adult case report as early as 1972 (Arnold, Strobl, &
Weisenberg, 1972). Unfortunately, semi-structured and structured interviews provide
imperfect insurance against surveillance effects, due to differences in training and
conceptualization: Disagreements about mania are high even when clinicians are presented
with identical vignettes (Dubicka, Carlson, Vail, & Harrington, 2008) or videotaped
interviews (Mackin, Targum, Kalali, Rom, & Young, 2006).
Surveillance bias could also work in the opposite direction, leading to inflated estimates of
comorbidity. If clinicians are concerned about the possibility of PBD in cases with ADHD,
then better monitoring may contribute to perception of an association between PBD and
ADHD. The literature about medication-induced mania may provide the strongest example
of this: Elevated rates of mania are found in open studies (where the observer and family
know that they are receiving active medication) but not in double-blind studies (Carlson,
2003; Joseph, Youngstrom, & Soares, 2009; Licht, Gijsman, Nolen, & Angst, 2008;
Scheffer, Kowatch, Carmody, & Rush, 2005).
Potential “True Comorbidity” Between BPD and ADHD
It also is possible to have “true comorbidity.” Possible mechanisms include (1) overlapping
risk factors or common underlying dimensions of cognitive, behavioral, or affective
dysfunction, (2) comorbidity creating a distinct, meaningful syndrome, and (3) one disorder
increasing risk for the other (Caron & Rutter, 1991). All three probably contribute to the
comorbidity between ADHD and PBD.
(1) Overlapping Risk Factors—To date, identified risk factors for bipolar disorder are
all non-specific (Tsuchiya, Byrne, & Mortensen, 2003). Several candidate genes for bipolar
disorder have been implicated in ADHD, unipolar depression, and schizophrenia, among
other conditions (Faraone, Glatt, & Tsuang, 2003). Not surprisingly there is substantial
neurocognitive overlap between BPD and ADHD, including deficits in response inhibition,
working memory, and other executive functions. Low birth weight, pre- and peri-natal
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insult, and abuse and trauma all are associated with both mood and attention problems (Hack
et al., 2004). Even family history of BPD is not specifically limited to risk of developing
PBD: Offspring of a parent with BPD have increased risk of many different poor outcomes,
including ADHD (Hodgins, Faucher, Zarac, & Ellenbogen, 2002). The correlation between
BPD and ADHD may be the product of each being independently associated with the same
underlying third variable – the shared risk factor.
Alternatively, there is evidence of some specificity in risk factors for BPD and ADHD. For
example, polymorphisms in genes important for calcium channel function (ex. CACNA1C)
have been associated with bipolar disorder (Sklar et al., 2008), but have not yet been
implicated in ADHD. Deletions or mutations in CACNA1C may result in episodic neural
dysfunction (Gargus, 2009) and provide a molecular basis for the episodic vs. chronic
distinction between BPD and ADHD. These possibilities for shared or differentiated genetic
mechanisms remain tentative, given the frequent failures to replicate findings in the early
stages of development of genetic research in this area. Another limitation of the extant
literature is that studies almost always examine cases versus unaffected controls, which
cannot identify whether genes are specific to ADHD or bipolar, versus being a shared
mechanism.
Additionally, a meta-analysis of neurocognitive functioning in pediatric bipolar disorder
identified substantial declines in verbal learning and long-term memory with intact
intellectual abilities (Joseph, Frazier, Youngstrom, & Soares, 2008). In contrast, individuals
with ADHD show little, if any, verbal memory dysfunction but moderate to large (~9 point)
IQ reduction relative to healthy controls. This suggests that the substantial, but incomplete,
BPD-ADHD comorbidity may be due to a combination of shared and specific risk factors.
(2) Comorbidity as Distinct Subtype—Comorbidity may also indicate a distinct,
meaningful subtype. Some argue that comorbid ADHD may be a characteristic of a
pediatric-onset variant of bipolar disorder (Faraone, Biederman, Mennin, Wozniak, &
Spencer, 1997). The “comorbid ADHD and bipolar” subtype might be a version that has
more chronic course and impairment. However, the symptoms of comorbid ADHD often
persist even after mood symptoms have responded to intervention, and then respond well to
adjunctive treatment with stimulants (Findling et al., 2005; Scheffer, et al., 2005). The
treatment response findings challenge the model that these symptoms are all part of a unitary
pediatric subtype and suggest that it might be a “true comorbidity” involving two distinct
conditions. Alternatively, differential treatment response may simply reflect targeting
different branches on the same tree (Figure 1).
(3) Causal Relationships (Prodrome & Risk Factors)—The third possibility, that
ADHD or BPD might create an increased risk of the other condition, is also plausible,
although it has yet to be demonstrated in prospective longitudinal studies (cf. Kim-Cohen et
al., 2003). Given the typical ages of onset, it is more likely that ADHD might be a risk factor
for PBD than the other way around. PBD also may lead to enough behavior problems to
technically satisfy criteria for a second disorder, but in this instance the behaviors would be
a bipolar-induced “phenocopy” of the other condition. All of the symptoms of ADHD could
be observed as part of a hypomanic or manic episode. Figure 2 illustrates how the symptom
of poor concentration can be the product of multiple different factors, and how it can be
associated with multiple diagnoses. If the only sample of behavior is taken from a manic
episode, it would be impossible to tell whether the ADHD symptoms were completely
attributable to the mania versus a separate condition. It is unknown whether the mechanisms
producing the inattention, hyperactivity, and impulsiveness in mania are identical to the
mechanisms underlying ADHD, but the overlap in risk factors and some aspects of
neurocognitive functioning (Joseph, Frazier, Youngstrom, & Soares, 2008) could be
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consistent with shared processes. ADHD also could lead to greater family conflict, increased
stress through disrupted peer and academic functioning, and increased substance use, with
each factor mediating the increased risk for development of BPD.
Deciding Which Is “Primary”
Because there are no symptoms unique to ADHD, there are two main strategies to
disentangle the diagnoses. One is to focus on symptoms that are more specific to mania,
such as elated mood, grandiosity and unstable self esteem, or decreased need for sleep (as
distinct from restless sleep or insomnia; see Figure 3) and possibly including neurocognitive
deficits that are more specific to bipolar disorder, such as verbal learning and memory
(Joseph, et al., 2008;Kaplan, Dewey, Crawford, & Fisher, 1998). The other strategy is to
assess the course of the symptoms: A more episodic presentation is suggestive of a mood
disorder, and a more chronically persistent presentation suggests ADHD. Putting these
strategies together, chronically persistent inattention, distractibility, hyperactivity, and
impulsiveness without high-specificity, non-overlapping symptoms of mania or episodic
exacerbations is “pure” ADHD, whereas episodic symptoms that include high-specificity
symptoms constitute mania. Chronic hyperactivity, impulsiveness, and attention problems
with episodic exacerbation would be consistent with comorbid PBD superimposed on
ADHD (Youngstrom, Birmaher, & Findling, 2008).
How do clinicians or researchers decide which diagnosis is “primary” when both could be
coded as present? The term “primary” can connote which came first developmentally, which
is worst in terms of severity, which causes the other (as in the third model of true
comorbidity, above), or which brings the youngster to clinical attention. In most cases of
true comorbidity, classifying the BPD as primary is consistent with the usual comparative
severity, alerts the clinician and family to be vigilant for episodes, and expedites the
treatment plan (and with some insurance plans, may facilitate coverage).
Implications for Research and Practice
Because all ADHD symptoms can also be BPD symptoms, both investigators and clinicians
need to pay great attention to ADHD Criterion E, the exclusionary criterion, that the
symptoms are not better accounted for by another disorder. A convenient rule of thumb is
that the symptoms do not exclusively occur during another disorder, such as during manic
episodes –the chronic vs. episodic rule. Implementation of criterion E requires a complete
psychiatric history and mental status exam, which may uncover non-overlapping symptoms
as well as delineate the time course of the common symptoms. Paradoxically, a mental
status exam cannot be used to diagnose ADHD because of most children's lack of insight
about their own inattentiveness/distractibility/impulsivity/hyperactivity and the fact that they
may not show it in a novel 1:1 situation; but ADHD can often be excluded by mental status
exam. This issue needs more investigation by primary medical practitioners and probably in
epidemiologic studies.
When both ADHD and BPD are diagnosed together, it is usually clinically useful to consider
the BPD the initial and primary target of treatment even if the ADHD came first
chronologically for two reasons: (a) the greater severity and more sinister prognosis of BPD;
and (b) the risk that medications for ADHD may exacerbate bipolar symptoms if the patient
is not first “covered” by a mood stabilizer. In some cases there may be only symptoms of
ADHD with no non-overlapping symptoms, but the symptoms are of such intensity that the
clinician suspects they may constitute a prodrome of BPD, especially with a family history
of BPD. In that case, it is acceptable to first treat the ADHD (possibly considering a
nonstimulant medicaton rather than stimulant), but inform the family, monitor very closely
for breakthrough of mania, and be prepared to institute a mood stabilizer emergently. The
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MTA results suggest that most such cases do not have an adverse reaction to ADHD
medication (Galanter, et al., 2003). In such cases behavioral treatment will be especially
important both for containing behavioral symptoms and for reducing the dose of ADHD
medication needed for optimal results (MTA Cooperative Group, 1999).
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The Tree Metaphor for Bipolar Disorder Pathology, Etiologies, and Possibly Related
Disorders: Equipotentiality of roots, multifinality of clinical course and presentations.
Note: Eating D/O = Eating Disorder; OCD = Obsessive/Compulsive Disorder; ADHD =
Attention-Deficit/Hyperactivity Disorder; CD/APD = Conduct Disorder/Antisocial
Personality Disorder; Impulse D/O = Impulse control Disorder; TBI = Traumatic Brain
Injury
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Interplay between contributing factors, mood states, and other diagnoses in equifinality of
“poor concentration.” Dashed lines indicate that poor concentration is part of the diagnostic
criteria for the disorder or a common associated symptom. Solid lines indicate probable
causal relationships.
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Interplay between contributing factors, mood states, and other diagnoses in equifinality of
“decreased need for sleep.” Decreased need for sleep, with high levels of energy, is distinct
from difficulty falling asleep or insomnia – which would not be specific to bipolar disorder
and which would show relationship with all of the disorders listed below. Dashed lines
indicate that decreased need for sleep is part of the diagnostic criteria for the disorder. Solid
lines indicate probable causal relationships.
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